Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 9, 2021

View Archived Issues

Discovery and preclinical characterization of a novel anti-SARS-CoV-2 MAb, MW-06

Heparegenix identifies new MAPKK 4 inhibitors

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent PROTACs targeting cereblon

Dongguan Hec New Drug Research and Development, Sunshine Lake Pharma identify HBV inhibitors

New SHP-2 inhibitors identified at Beijing Innocare Pharmaceutical Technology

ImmVira receives NMPA approval for clinical testing of intravenous MVR-T3011

Ichnos nominates ISB-1442 as its next clinical candidate

Targeting synaptogyrin-3 can ameliorate cognitive deficits

AIkido to use machine learning in development of novel broad-spectrum antivirals

Initial results presented from first-in-human study of ABNCoV2 vaccine

Bentrio shows prophylactic and therapeutic effects against influenza A

Proteins found to promote neuroinflammation in MS

Phase II study of ASC-40 for the treatment of acne vulgaris approved in China

Antengene and MindRank AI collaborate to advance difficult-to-drug molecular targets

Enrollment ongoing in phase II study of USB-002 for respiratory distress due to COVID-19

Signal peptide peptidase-like 2B has a pathogenic role in Alzheimer's disease

Atridia initiates phase I study of SHR-1905

Initiation of phase I/II clinical trial of AK-117 in patients with AML

AstraZeneca starts phase II SOLANO study of AZD-8233

Response rate shows potential of ficlatuzumab with chemotherapy in treating AML

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...